• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: doxorubicin
Date Designated: 04/06/2015
Orphan Designation: Treatment of cutaneous T-cell lymphoma
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Louis D. Falo, Jr.
University of Pittsburgh, Dep. of Dermatology
3500 Fifth Avenue
Pittsburgh, Pennsylvania 15213
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.